Successful treatment of hemorrhagic bullous Henoch-Schonlein purpura with intravenous immunoglobulins

Abstract

Henoch-Schonlein purpura (HSP) is the most common systemic vasculitis in childhood. There is no consensus about the management for isolated cutaneous manifestations in HSP. We describe a case of HSP presenting with severe skin lesions that did not respond to standard therapy with corticosteroids. The 11-year-old child was treated with intravenous immunoglobulins, which induced rapid and persistent resolution of symptomatology.

Keywords: Henoch-Schonlein purpura; hemorrhagic bullous; intravenous immunoglobulin; treatment.